LEADER 05409nam 22006613u 450 001 9910459523303321 005 20210114042510.0 010 $a1-4399-0702-1 035 $a(CKB)2670000000059339 035 $a(EBL)631701 035 $a(OCoLC)813295905 035 $a(SSID)ssj0000472174 035 $a(PQKBManifestationID)11300960 035 $a(PQKBTitleCode)TC0000472174 035 $a(PQKBWorkID)10433353 035 $a(PQKB)11234727 035 $a(MiAaPQ)EBC631701 035 $a(EXLCZ)992670000000059339 100 $a20131216d2010|||| u|| | 101 0 $aeng 181 $ctxt 182 $cc 183 $acr 200 10$aPolicy and Politics in Canada$b[electronic resource] 210 $aPhiladelphia $cTemple University Press$d2010 215 $a1 online resource (418 p.) 225 1 $aPolicy and politics in industrial states 300 $aDescription based upon print version of record. 311 $a0-87722-870-1 327 $aContents; Editors' Preface; Preface; 1. Introduction; The Roots of Ambivalence; The Institutionalization of Ambivalence; The Organization of Interests; Conclusions; Notes; 2. Constitutional Change; Context; Agenda; Process; Consequences; Readings; 2-1: The Pequiste Manifesto; 2-2: The Federal Response to Quebec's Constitutional Agenda; 2-3: The Quebec Referendum; 2-4: Entrenched Rights versus Parliamentary Supremacy; 2-5: The Quebec Liberal's Constitutional Position during the 1980 Referendum Campaign; 2-6: The Meech Lake Accord (Excerpts); 2-7: Trudeau's Criticism of the Accord 327 $a2-8: One Legislator's Ambivalence Notes; 3. Health Care Delivery; Context; Agenda; Process; Consequences; Readings; 3-1: A Health Charter for Canadians; 3-2: Governmental Insurance and Clinical Judgement: A Medical View; 3-3: The Canadian Medical Association and Canadian Medicare; 3-4: The Canadian Nurses Association and Canadian Medicare; 3-5: A Consumers' Coalition Seeks a Community-Based Health Plan; 3-6: Extra-Billing and the Universality of Social Programs; 3-7: The Medical Profession Seeks a Partnership with Government; 3-8: The Policy Agenda of the 1990's at the Provincial Level; Notes 327 $a4. Industrial Relations and Labour-Market Policy Context; Agenda; Process; Consequences; Readings; 4-1 and 4-2: The Business View of Labour-Management Cooperation; 4-3: Labour's Approach to Social Partnership; 4-4: Government as a Catalyst in Labour-Management Cooperation; 4-5: An Evaluation of Government Adjustment Assistance; 4-6: Labour on Collective Bargaining and Labour-Market Policy; Notes; 5. Economic Development and Adjustment; Context; Agenda; Process; Consequences; Readings; 5-1: The BCNI Critique of Canadian Industrial Policy 327 $a5-2: Labour's Goals: Full Employment and Greater Public Control 5-3: The Macdonald Commission on Canada-U.S. Trade; 5-4: Labour's Focus on Full Employment; 5-5: The Commons Debate on the Free Trade Agreement; Notes; 6. Oil and Gas Policy; Context; Agenda; Process; Consequences; Readings; 6-1: The Gordon Commission's View of Foreign Investment in Canadian Oil; 6-2: Western Canadian Resistance to the National Energy Program; 6-3: The Federal Defense of the National Energy Program; 6-4: The Business Community and the National Energy Program 327 $a6-5: Federal and Provincial Powers over Natural Resources Notes; 7. Minority Language Rights; Context; Agenda; Process; Consequences; Readings; 7-1: Trudeau on Language Rights; 7-2: Levesque on Francophones outside Quebec; 7-3: The Manifesto of Quebec's Radical Nationalists; 7-4: The Union Nationale Government on the Status of French; 7-5: The Courts on Linguistic Education Rights; 7-6: Language Rights in the Canadian Charter of Rights and Freedom; 7-7: The Commissioner of Official Languages on Multiculturalism; Notes; 8. Competence and Crisis: Canada's Ambivalent Institutions 327 $aElite Accommodation: The Role of Mediating Interests 330 $aAt a time when Canadian political institutions are being fundamentally questioned, this book provides a comparative perspective on the distinctive features of the Canadian policy process which have enabled conflict to be resolved in the past. In comparison with other Western industrial nations, Canada's policies in some arenas appear as models of workable compromise; in others, they stand out as marked by continuing irresolution. In this first book-length treatment of Canadian public policy in comparative perspective, Carolyn Tuohy focuses on constitutional change, health care delivery, 410 0$aPolicy and politics in industrial states 606 $aCanada -- Economic policy 606 $aCanada -- Politics and government -- 1945- 606 $aCanada -- Social policy 606 $aPolitical planning -- Canada 606 $aPolitical planning$zCanada 608 $aElectronic books. 615 4$aCanada -- Economic policy. 615 4$aCanada -- Politics and government -- 1945-. 615 4$aCanada -- Social policy. 615 4$aPolitical planning -- Canada. 615 0$aPolitical planning 676 $a320.60971 676 $a320/.6/0971 700 $aTuohy$b Carolyn Hughes$f1945-$0886073 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910459523303321 996 $aPolicy and Politics in Canada$91978668 997 $aUNINA LEADER 04699nam 2200613 450 001 9910459912303321 005 20200520144314.0 010 $a1-58528-426-2 035 $a(CKB)3710000000277355 035 $a(EBL)3115752 035 $a(SSID)ssj0001370038 035 $a(PQKBManifestationID)12576099 035 $a(PQKBTitleCode)TC0001370038 035 $a(PQKBWorkID)11309056 035 $a(PQKB)11680149 035 $a(MiAaPQ)EBC3115752 035 $a(Au-PeEL)EBL3115752 035 $a(CaPaEBR)ebr10983529 035 $a(OCoLC)922966284 035 $a(EXLCZ)993710000000277355 100 $a20141118h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aPediatric pharmacotherapy self assessment /$fSandra Benavides, Hanna Phan, Milap C. Nahata ; contributors, Mary A. Babico [and twenty-one others] 210 1$aBethesda, Maryland :$cASHP Publications,$d2015. 210 4$dİ2015 215 $a1 online resource (285 p.) 300 $aDescription based upon print version of record. 311 $a1-58528-424-6 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $a""titlepage""; ""table of contents""; ""contributors""; ""preface""; ""acknowledgments""; ""1.1 Pediatric Patient Care Management""; ""Part One - Cases""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2""; ""CASE 3.3 Congenital Heart Defects | Level 3""; ""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1"" 327 $a""CASE 5.2 Crohn Disease | Level 2""""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1""; ""CASE 8.2 Autism Spectrum Disorder | Level 2""; ""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1"" 327 $a""CASE 9.3 Parasitic Infections | Level 2""""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3""; ""PART 2 | QUESTIONS & ANSWERS""; ""CASE 2.1 Anaphylaxis | Level 1""; ""CASE 2.2 Nutrition | Level 2""; ""CASE 2.3 Toxicology | Level 3""; ""CASE 3.1 Patent Ductus Arteriosus | Level 1""; ""CASE 3.2 Hypertension | Level 2"" 327 $a""CASE 3.3 Congenital Heart Defects | Level 3""""CASE 4.1 Asthma | Level 1""; ""CASE 4.2 Cystic Fibrosis | Level 2""; ""CASE 4.3 Respiratory Distress Syndrome and Bronchopulmonary Dysplasia | Level 3""; ""CASE 5.1 Constipation | Level 1""; ""CASE 5.2 Crohn Disease | Level 2""; ""CASE 6.1 Nephrotic Syndrome | Level 2""; ""CASE 6.2 Acute Kidney Injury | Level 3""; ""CASE 7.1 Type 2 Diabetes Mellitus | Level 1""; ""CASE 7.2 Hypothyroidism | Level 2""; ""CASE 7.3 Diabetic Ketoacidosis | Level 3""; ""CASE 8.1 Attention Deficit Hyperactivity Disorder | Level 1"" 327 $a""CASE 8.2 Autism Spectrum Disorder | Level 2""""CASE 8.3 Depression | Level 2""; ""CASE 8.4 Cerebral Palsy | Level 3""; ""CASE 8.5 Seizure Disorders | Level 3""; ""CASE 9.1 Acute Otitis Media | Level 1""; ""CASE 9.2 Skin and Skin Structure Infections | Level 1""; ""CASE 9.3 Parasitic Infections | Level 2""; ""CASE 9.4 Pneumonia | Level 2""; ""CASE 9.5 Kawasaki Disease | Level 3""; ""CASE 9.6 Human Immunodeficiency Virus Infection | Level 3""; ""CASE 9.7 Meningitis | Level 3""; ""CASE 10.1 Anemia | Level 1""; ""CASE 10.2 Sickle Cell Disease | Level 2""; ""CASE 10.3 Anticoagulation | Level 3"" 327 $a""APPENDIXES"" 606 $aPediatric pharmacology 608 $aElectronic books. 615 0$aPediatric pharmacology. 676 $a615.1083 700 $aBenavides$b Sandra$0869432 702 $aPhan$b Hanna$f1979- 702 $aNahata$b Milap C. 702 $aBabico$bMary A. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910459912303321 996 $aPediatric pharmacotherapy self assessment$91941179 997 $aUNINA